Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The British Journal of Radiology
|
December 21, 2022
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort
Kundan Singh Chufal, Irfan Ahmad, Ram Bajpai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2025
Depth of Invasion as an Independent Indication for Postoperative Radiation Therapy in Oral Tongue Squamous Cell Carcinoma
Sarthak Tandon, Parveen Ahlawat, Shaifali Mahajan, et al.
Oncology and Therapy
|
October 17, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival
Ullas Batra, Mansi Sharma, Irfan Ahmad, et al.
Immunotherapy
|
September 5, 2025
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap
Ullas Batra, Mansi Sharma, Alexis Andrew Miller, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The British Journal of Radiology
|
December 21, 2022
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort
Kundan Singh Chufal, Irfan Ahmad, Ram Bajpai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2025
Depth of Invasion as an Independent Indication for Postoperative Radiation Therapy in Oral Tongue Squamous Cell Carcinoma
Sarthak Tandon, Parveen Ahlawat, Shaifali Mahajan, et al.
Oncology and Therapy
|
October 17, 2025
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival
Ullas Batra, Mansi Sharma, Irfan Ahmad, et al.
Immunotherapy
|
September 5, 2025
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap
Ullas Batra, Mansi Sharma, Alexis Andrew Miller, et al.
Page
of 2